NASDAQ:SILK

Silk Road Medical Stock Forecast, Price & News

$50.18
+5.72 (+12.87 %)
(As of 07/30/2021 12:00 AM ET)
Add
Compare
Today's Range
$46.29
$52.40
50-Day Range
$44.00
$52.59
52-Week Range
$43.11
$75.80
Volume870,761 shs
Average Volume277,084 shs
Market Capitalization$1.73 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.48
30 days | 90 days | 365 days | Advanced Chart
Receive SILK News and Ratings via Email

Sign-up to receive the latest news and ratings for Silk Road Medical and its competitors with MarketBeat's FREE daily newsletter.


Silk Road Medical logo

About Silk Road Medical

Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products includes ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.24 out of 5 stars

Medical Sector

1011th out of 2,223 stocks

Surgical & Medical Instruments Industry

101st out of 185 stocks

Analyst Opinion: 2.3Community Rank: 3.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Silk Road Medical (NASDAQ:SILK) Frequently Asked Questions

Is Silk Road Medical a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Silk Road Medical stock.
View analyst ratings for Silk Road Medical
or view top-rated stocks.

What stocks does MarketBeat like better than Silk Road Medical?

Wall Street analysts have given Silk Road Medical a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Silk Road Medical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Silk Road Medical's next earnings date?

Silk Road Medical is scheduled to release its next quarterly earnings announcement on Tuesday, November 9th 2021.
View our earnings forecast for Silk Road Medical
.

How were Silk Road Medical's earnings last quarter?

Silk Road Medical, Inc (NASDAQ:SILK) released its quarterly earnings data on Thursday, July, 29th. The company reported ($0.31) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.37) by $0.06. Silk Road Medical had a negative trailing twelve-month return on equity of 44.13% and a negative net margin of 53.85%.
View Silk Road Medical's earnings history
.

How has Silk Road Medical's stock been impacted by Coronavirus?

Silk Road Medical's stock was trading at $37.14 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, SILK stock has increased by 35.1% and is now trading at $50.18.
View which stocks have been most impacted by COVID-19
.

What guidance has Silk Road Medical issued on next quarter's earnings?

Silk Road Medical issued an update on its FY 2021 earnings guidance on Thursday, July, 29th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $104 million-$109 million, compared to the consensus revenue estimate of $106.04 million.

What price target have analysts set for SILK?

4 analysts have issued 1 year price targets for Silk Road Medical's stock. Their forecasts range from $55.00 to $75.00. On average, they anticipate Silk Road Medical's stock price to reach $61.00 in the next year. This suggests a possible upside of 21.6% from the stock's current price.
View analysts' price targets for Silk Road Medical
or view top-rated stocks among Wall Street analysts.

Who are Silk Road Medical's key executives?

Silk Road Medical's management team includes the following people:
  • Ms. Erica J. Rogers, Pres, CEO & Director (Age 57, Pay $497.12k)
  • Mr. Lucas W. Buchanan, CFO & COO (Age 44, Pay $715.23k)
  • Mr. Andrew S. Davis, Chief Commercial Officer (Age 52, Pay $655.83k)
  • Mr. Richard M. Ruedy, Exec. VP of Clinical, Regulatory Affairs & Quality Assurance (Age 54, Pay $433.06k)
  • Ms. Mhairi L. Jones, VP of Fin. & Accounting
  • Mr. William Hill, Gen. Counsel
  • Mr. Matthew McCarthy, VP of Marketing
  • Ms. Alison Highlander, VP of HR
  • Dr. Sumaira MacDonald, Exec. Medical Director
  • Dr. William Whealon Ph.D., Exec. VP of R&D

Who are some of Silk Road Medical's key competitors?

What other stocks do shareholders of Silk Road Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include Raytheon Technologies (RTX), The Procter & Gamble (PG), Abbott Laboratories (ABT), Cisco Systems (CSCO), Pfizer (PFE), Edwards Lifesciences (EW), Honeywell International (HON), CSX (CSX), Thermo Fisher Scientific (TMO) and Alibaba Group (BABA).

When did Silk Road Medical IPO?

(SILK) raised $75 million in an initial public offering on Thursday, April 4th 2019. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers.

What is Silk Road Medical's stock symbol?

Silk Road Medical trades on the NASDAQ under the ticker symbol "SILK."

Who are Silk Road Medical's major shareholders?

Silk Road Medical's stock is owned by a variety of institutional and retail investors. Top institutional investors include Alliancebernstein L.P. (6.97%). Company insiders that own Silk Road Medical stock include Andrew S Davis, Erica J Rogers, Jack W Lasersohn, Lucas W Buchanan, Pincus & Co Warburg and Richard Ruedy.
View institutional ownership trends for Silk Road Medical
.

Which institutional investors are buying Silk Road Medical stock?

SILK stock was purchased by a variety of institutional investors in the last quarter, including Alliancebernstein L.P..
View insider buying and selling activity for Silk Road Medical
or or view top insider-buying stocks.

How do I buy shares of Silk Road Medical?

Shares of SILK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Silk Road Medical's stock price today?

One share of SILK stock can currently be purchased for approximately $50.18.

How much money does Silk Road Medical make?

Silk Road Medical has a market capitalization of $1.73 billion and generates $75.23 million in revenue each year. The company earns $-47,370,000.00 in net income (profit) each year or ($1.44) on an earnings per share basis.

How many employees does Silk Road Medical have?

Silk Road Medical employs 281 workers across the globe.

What is Silk Road Medical's official website?

The official website for Silk Road Medical is www.silkroadmed.com.

Where are Silk Road Medical's headquarters?

Silk Road Medical is headquartered at 1213 INNSBRUCK DR., SUNNYVALE CA, 94089.

How can I contact Silk Road Medical?

Silk Road Medical's mailing address is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. The company can be reached via phone at 408-720-9002 or via email at [email protected]


This page was last updated on 7/31/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.